Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic β-cells

Molecular Endocrinology

Volumn 23, Issue 10, 2009, Pages 1572-1586

  Pétremand, Jannick ^a   Bulat, Natasa ^a   Butty, Anne Christine ^a,b   Poussin, Carine ^a   Rütti, Sabine ^d   Au, Karin ^c   Ghosh, Sujoy ^c   Mooser, Vincent ^c   Thorens, Bernard ^a   Yang, Jiang Yan ^a   Widmann, Christian ^a   Waeber, Gérard ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAP BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INTERLEUKIN 1BETA; SHORT HAIRPIN RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; EMBRYO; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA TRANSLATION; STARVATION; STRESS; TRANSCRIPTOMICS; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACIDS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CARRIER PROTEINS; CELL LINE, TUMOR; CHOLESTEROL; CYTOPROTECTION; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HUMANS; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; LIPOPROTEINS, HDL; MICE; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; SERUM; STRESS, PHYSIOLOGICAL;

EID: 70349770784     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0448     Document Type: Article

References (58)

1. Stumvoll M, Goldstein BJ, van Haeften TW 2005 Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333-1346 (Pubitemid 40501297)
2. Permutt MA, Wasson J, Cox N 2005 Genetic epidemiology of diabetes. J Clin Invest 115:1431-1439
3. Frayling TM 2007 Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657-662 (Pubitemid 47281993)
4. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, Timpson NJ, Perry JR, Rayner NW, Freathy RM, Barrett JC, Shields B, Morris AP, Ellard S, Groves CJ, Harries LW, Marchini JL, Owen KR, Knight B, Cardon LR, Walker M, Hitman GA, Morris AD, Doney AS, McCarthy MI, et al. 2007 Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341 (Pubitemid 46871654)
5. Shepherd J 2007 Dyslipidaemia in diabetic patients: time for a rethink. Diabetes Obes Metab 9:609-616 (Pubitemid 47261843)
6. Tenenbaum A, Motro M, Fisman EZ, Schwammenthal E, Adler Y, Goldenberg I, Leor J, Boyko V, Mandelzweig L, Behar S 2004 Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation 109:2197-2202 (Pubitemid 38656105)
7. Pétremand J, Abderrahmani A, Widmann C 2008 Genetics and molecular biology: HDLs and their multiple ways to protect cells. Curr Opin Lipidol 19:95-97
8. Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S, Bideau M, Capponi A, Nicod P, Haefliger JA, Waeber G 2003 Insulin-secreting β-cell dysfunction induced by human lipoproteins. J Biol Chem 278:18368-18375 (Pubitemid 36799458)
9. Abderrahmani A, Niederhauser G, Favre D, Abdelli S, Ferdaoussi M, Yang JY, Regazzi R, Widmann C, Waeber G 2007 Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic β cells. Diabetologia 50:1304-1314 (Pubitemid 46701553)
10. Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, de Courten B, Forbes JM, Yap FY, Kaye DM, van Hall G, Febbraio MA, Kemp BE, Sviridov D, Steinberg GR, Kingwell BA 2009 High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 119:2103-2111
11. Ilieva A, Yuan S, Wang RN, Agapitos D, Hill DJ, Rosenberg L 1999 Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J Endocrinol 161:357-364 (Pubitemid 29278791)
12. Rosso D, Carnazzo G, Giarelli L, Motta L, Maugeri D 2001 Atherosclerosis and pancreatic damage. Arch Gerontol Geriatr 32:95-100
13. Rader DJ 2006 Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 116:3090-3100
14. Dobreva I, Zschörnig O, James RW, Waeber G, Widmann C 2005 Cholesterol is the major component of native lipoproteins activating the p38 MAPKs. Biol Chem 368:909-918
15. Graf GA, Connell PM, van der Westhuyzen DR, Smart EJ 1999 The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. J Biol Chem 274:12043-12048 (Pubitemid 129518466)
16. Horton JD, Goldstein JL, Brown MS 2002 SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131
17. Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F 2004 SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86:839-848 (Pubitemid 39602764)
18. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL 2003 Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 100:12027-12032
19. Sachs AB, Varani G 2000 Eukaryotic translation initiation: there are (at least) two sides to every story. Nat Struct Biol 7:356-361 (Pubitemid 30249995)
20. Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N 1996 Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 15:658-664 (Pubitemid 26044579)
21. Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N, Lawrence Jr JC 1994 PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266:653-656 (Pubitemid 24363524)
22. Haghighat A, Mader S, Pause A, Sonenberg N 1995 Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J 14:5701-5709
23. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N 1999 Regulation of 4EBP1 phosphorylation: a novel two-step mechanism. Genes Dev 13: 1422-1437 (Pubitemid 29270247)
24. Jiang YP, Ballou LM, Lin RZ 2001 Rapamycin-insensitive regulation of 4e-BP1 in regenerating rat liver. J Biol Chem 276:10943-10951 (Pubitemid 38089273)
25. Scheuner D, Kaufman RJ 2008 The unfolded protein response: a pathway that links insulin demand with β-cell failure and diabetes. Endocr Rev[Erratum (2008)29:631] 29:317-333 (Pubitemid 351679702)
26. Yamaguchi S, Ishihara H, Yamada T, Tamura A, Usui M, Tominaga R, Munakata Y, Satake C, Katagiri H, Tashiro F, Aburatani H, Tsukiyama-Kohara K, Miyazaki J, Sonenberg N, Oka Y 2008 ATF4-mediated induction of 4E-BP1 contributes to pancreatic β cell survival under endoplasmic reticulum stress. Cell Metab 7:269-276 (Pubitemid 351285529)
27. ++ release by endoplasmic reticulum and caspase-12 activation. Brain Res 1147:1-11
28. Hoppe V, Hoppe J 2004 Mutations dislocate caspase-12 from the endoplasmatic reticulum to the cytosol. FEBS Lett 576:277-283 (Pubitemid 39330497)
29. Brewster JL, Linseman DA, Bouchard RJ, Loucks FA, Precht TA, Esch EA, Heidenreich KA 2006 Endoplasmic reticulum stress and trophic factor withdrawal activate distinct signaling cascades that induce glycogen synthase kinase-3 β and a caspase-9-dependent apoptosis in cerebellar granule neurons. Mol Cell Neurosci 32:242-253
30. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J 2000 Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403:98-103 (Pubitemid 30038529)
31. Keller GA, West MA, Harty JT, Wilkes LA, Cerra FB, Simmons RL 1985 Modulation of hepatocyte protein synthesis by endotoxin-activated Kupffer cells. III. Evidence for the role of a monokine similar to but not identical with interleukin-1. Ann Surg 201:436-443
32. Broussard SR, McCusker RH, Novakofski JE, Strle K, Shen WH, Johnson RW, Dantzer R, Kelley KW 2004 IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. J Immunol 172:7713-7720 (Pubitemid 38747638)
33. Magagnin MG, van den Beucken T, Sergeant K, Lambin P, Koritzinsky M, Devreese B, Wouters BG 2008 The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency. Proteomics 8:1019-1028
34. Robbesyn F, Garcia V, Auge N, Vieira O, Frisach MF, Salvayre R, Negre-Salvayre A 2003 HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-κB activation in smooth muscle cells. FASEB J 17:743-745
35. Schmidt A, Geigenmüller S, Völker W, Buddecke E 2006 The antiatherogenic and antiinflammatory effect of HDL-associated lysosphingolipids operates via Akt → NF-κB signalling pathways in human vascular endothelial cells. Basic Res Cardiol 101:109-116
36. Park SH, Park JH, Kang JS, Kang YH 2003 Involvement of transcription factors in plasma HDL protection against TNF-α-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol 35:168-182
37. Kimura T, Tomura H, Mogi C, Kuwabara A, Damirin A, Ishizuka T, Sekiguchi A, Ishiwara M, Im DS, Sato K, Murakami M, Okajima F 2006 Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem 281:37457-37467 (Pubitemid 46042049)
38. Argraves KM, Argraves WS 2007 HDL serves as an S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 48:2325-2333
39. Mineo C, Deguchi H, Griffin JH, Shaul PW 2006 Endothelial and antithrombotic actions of HDL. Circ Res 98:1352-1364
40. Negre-Salvayre A, Dousset N, Ferretti G, Bacchetti T, Curatola G, Salvayre R 2006 Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med 41:1031-1040 (Pubitemid 44348872)
41. Rolli-Derkinderen M, Machavoine F, Baraban JM, Grolleau A, Beretta L, Dy M 2003 ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. J Biol Chem 278:18859-18867 (Pubitemid 36799268)
42. Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N 2006 mTOR, translation initiation and cancer. Oncogene 25:6416-6422
43. Holcik M, Sonenberg N 2005 Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6:318-327
44. Gingras AC, Raught B, Sonenberg N 2001 Regulation of translation initiation by FRAP/mTOR. Genes Dev 15:807-826
45. Spriggs KA, Stoneley M, Bushell M, Willis AE 2008 Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell 100:27-38 (Pubitemid 351201431)
46. Holcik M, Sonenberg N, Korneluk RG 2000 Internal ribosome initiation of translation and the control of cell death. Trends Genet 16:469-473 (Pubitemid 30758899)
47. Bushell M, Stoneley M, Kong YW, Hamilton TL, Spriggs KA, Dobbyn HC, Qin X, Sarnow P, Willis AE 2006 Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell 23:401-412 (Pubitemid 44128848)
48. Li S, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA, Bitterman PB 2002 Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Mol Cell Biol 22:2853-2861 (Pubitemid 34263005)
49. Polunovsky VA, Gingras AC, Sonenberg N, Peterson M, Tan A, Rubins JB, Manivel JC, Bitterman PB 2000 Translational control of the antiapoptotic function of Ras. J Biol Chem 275:24776-24780 (Pubitemid 30626581)
50. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, Eizirik DL 2001 Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB superrepressor prevents β-cell apoptosis. Diabetes 50:2219-2224 (Pubitemid 33641904)
51. Jordan M, Schallhorn A, Wurm FM 1996 Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 24:596-601 (Pubitemid 26085833)
52. Brummelkamp TR, Bernards R, Agami R 2002 A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553 (Pubitemid 34408678)
53. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L 2003 A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406 (Pubitemid 36278858)
54. Havel RJ, Eder HA, Bragdon JH 1955 The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353
55. James RW, Pometta D 1990 Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes 39:1158-1164 (Pubitemid 20327049)
56. 317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins. Mol Cancer Res 5:497-507
57. Smyth GK 2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3
58. Bonvin C, Guillon A, van Bemmelen MX, Gerwins P, Johnson GL, Widmann C 2002 Role of the amino-terminal domains of MEKKs in the activation of NFκB and MAPK pathways and in the regulation of cell proliferation and apoptosis. Cell Signal 14:123-131 (Pubitemid 34056584)